# Neoadjuvant Chemotherapy in Breast Cancer

> **NCT04802941** · NA · UNKNOWN · sponsor: **Center of Personalized Medicine, Pirogova** · enrollment: 1200 (estimated)

## Conditions studied

- Decision Support Systems, Clinical

## Interventions

- **DEVICE:** Neoadjuvant Chemotherapy by CDSS (MedicBK)
- **DRUG:** General practice

## Key facts

- **NCT ID:** NCT04802941
- **Lead sponsor:** Center of Personalized Medicine, Pirogova
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-12
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-03-30
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2021-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04802941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04802941, "Neoadjuvant Chemotherapy in Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04802941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*